CD27 Ligand

CD27 Ligand 분자 정보

영어 이름CD70 antigen시판 약물 수0
임상 약물 수37표적 별명CD70 antigen,Surface Antigen CD70,LPFS3,CD27L,Tumor necrosis factor ligand superfamily member 7,CD27LG,CD27-L,CD70,CD70 Molecule,TNFSF7,Tumor Necrosis Factor (Ligand) Superfamily, Member 7,Tumor Necrosis Factor Ligand 8A,Ki-24 Antigen,TNLG8A,CD27 Ligand
최고 연구 개발 단계Phase 2 Clinical
영어 이름CD70 antigen
표적 별명CD70 antigen,Surface Antigen CD70,LPFS3,CD27L,Tumor necrosis factor ligand superfamily member 7,CD27LG,CD27-L,CD70,CD70 Molecule,TNFSF7,Tumor Necrosis Factor (Ligand) Superfamily, Member 7,Tumor Necrosis Factor Ligand 8A,Ki-24 Antigen,TNLG8A,CD27 Ligand
시판 약물 수0
임상 약물 수37
최고 연구 개발 단계Phase 2 Clinical

CD27 Ligand 제품 목록

  • 속성

    Protein (14)

  • 제품 라이브러리

    온라인 (14)

  • Mouse (3)Human (11)

  • 태그

    Mouse IgG Fc Tag (2)His Tag (6)His Tag & Avi Tag (1)Fc Tag (1)His Tag & Flag Tag (2)His Tag & Avi Tag & Flag Tag (1)Llama IgG Fc Tag (1)

  • 마커

    Unconjugated (6)Biotin-labeled (2)FITC Labeled (2)APC Labeled (1)PE Labeled (1)AF647 Labeled (1)AF488 Labeled (1)

CD27 Ligand분자 배경

Cluster of Differentiation 70 (CD70) is also known as CD27 ligand (CD27L / CD27LG), TNFSF7, TNFSF7G, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and is a surface antigen found on activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor CD27 induces in priming, effector functions, differentiation and memory formation of T-cells, and thus is invloved in the biological processes including T-cell activation, the proliferation of costimulated T-cells, as well as the generation of cytolytic T-cells. CD70 on T cells provides costimulatory signals that are required for T cell proliferation, clonal expansion and the promotion of effector T cell formation. CD70 on mouse B cell has been shown to inhibit terminal differentiation of activated B cells into plasma cells and enhances commitment to memory B cell responses. CD70 induces proliferation and IFNγ production, on NK cells.

CD27 Ligand분자 별명

CD70,CD27LG,TNFSF7,TNFSF7G,CD27L

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
CD70 VHH - 01LeadMonoclonalNanobodyHematological MalignancyNon-hodgkin lymphoma

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CusatuzumabARGX-110; JNJ-4550Phase 2 ClinicalArgenx SeLeukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms
상세
ARX-305JNJ-0631; ARX-305; NCB-002Phase 2 ClinicalAmbrx IncLymphoma; Neoplasms
상세
CD70.CAR NK cell therapy (Bellicum Pharma)Phase 2 ClinicalBellicum Pharmaceuticals Inc, The University Of Texas MD Anderson Cancer CenterHodgkin Disease; Lymphoma, B-Cell
상세
ADI-270ADI-270Phase 2 ClinicalAdicet Bio IncCarcinoma, Renal Cell
상세
CD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)Phase 2 ClinicalUTC Therapeutics IncLymphoma; Solid tumours; Urologic Neoplasms
상세
Cord Blood-derived CAR NK Cells Targeting CD19/CD70(Shanghai Tongji Hospital)Phase 2 ClinicalShanghai Tongji HospitalLymphoma, B-Cell
상세
MP0533MP0533Phase 2 ClinicalMolecular Partners AgLeukemia, Myeloid, Acute
상세
CTX-131CTX-131Phase 2 ClinicalCrispr Therapeutics AgCarcinoma, Renal Cell; Esophageal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, T-Cell; Mesothelioma; Neoplasms; Pancreatic Neoplasms; Uterine Cervical Neoplasms
상세
GD2/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
상세
CD19/70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteLeukemia, B-Cell; Lymphoma, B-Cell
상세
PSMA/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR PSMA/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
상세
SEA-CD70SEA-CD70; PF-08046040Phase 1 ClinicalSeagen IncLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
anti-CD70 CAR T-cell therapy linked with modified IL-8 receptor (University of Florida)Phase 1 ClinicalUniversity Of FloridaGlioblastoma; Glioma; Ovarian Neoplasms; Pancreatic Neoplasms
상세
CAR BCMA-CD70-T cells therapy (The Fifth Medical Center Of Pla General Hospital)Phase 1 ClinicalThe Fifth Medical Center Of Pla General Hospital (Formerly 307 Hospital)Neoplasms, Plasma Cell
상세
Novel CAR-ITNK Cells Targeting CD70 and CLL1 therapy (Tongji Hospital)Phase 1 ClinicalTongji HospitalLeukemia, Myeloid, Acute
상세
TGFBR-2 KO CD70 CAR NK cell therapy (The University Of Texas MD Anderson Cancer Center)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer CenterAdenocarcinoma, Clear Cell
상세
GEN1160GEN-1160; GEN1160Phase 1 ClinicalGenmab A/SCarcinoma, Renal Cell; Lymphoma, Non-Hodgkin; Nasopharyngeal Carcinoma
상세
CD70-CAR-NK Cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineLeukemia, Myeloid, Acute; Lymphoma, T-Cell
상세
Anti-CD70-CAR-T Cell therapy(First Song Biotechnology)Phase 1 ClinicalShanghai First Song Therapeutics Co LtdCarcinoma, Renal Cell
상세
IB-T101Phase 1 ClinicalInceptor Bio LLCCarcinoma, Renal Cell
상세
Anti-BCMA/CD70 CAR-T cells therapy(The Children'S Hospital, Zhejiang University School Of Medicine)Phase 1 ClinicalThe Children'S Hospital, Zhejiang University School Of MedicineLupus Erythematosus, Systemic; Nephrosis
상세
CD70 UCAR T cells Therapy (Nanjing Calmhome Cell and Gene Engineering Institute)CHT101; CHT-101Phase 1 ClinicalNanjing Calmhome Cell and Gene Engineering Institute Co LtdCarcinoma, Renal Cell; Glioma; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
상세
Chimeric Antigen Recertor Treatment Targeting CD70(Baylor College of Medicine)Phase 1 ClinicalBaylor College Of MedicineBone Marrow Neoplasms; Kidney Neoplasms; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Sarcoma; Solid tumours
상세
CAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)Phase 1 ClinicalSt. Jude Children'S Research HospitalHematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
CD70-targeted CAR-NKT Cells Therapy (CureGenetics)CGC729; CGC-729Phase 1 ClinicalSuzhou Cure Genetics Biosciences Co LtdCarcinoma, Renal Cell; Solid tumours
상세
ALLO-329ALLO-329Phase 1 ClinicalAllogene Therapeutics IncAnti-synthetase Syndrome; Dermatomyositis; Lupus Erythematosus, Systemic; Muscular Diseases; Myositis; Scleroderma, Systemic
상세
CD70-CART(Hrain)HR010; HR-010Phase 1 ClinicalHrain Biotechnology Co LtdCarcinoma, Renal Cell
상세
Anti-CD19/CD70 NK cell therapy (Zhejiang University)Phase 1 ClinicalZhejiang UniversityLymphoma, B-Cell
상세
CD70 CAR-T cell therapy (Chongqing Precision Biotech)Phase 1 ClinicalChongqing Precision Biotechnology Co LtdArthritis, Juvenile; Carcinoma, Renal Cell; Dermatomyositis; Genital Neoplasms, Female; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Scleroderma, Systemic; Sjogren's Syndrome; Solid tumours; Thymoma; Thyroid Carcinoma, Anaplastic; Uterine Cervical Neoplasms
상세
IMM-40HIMM-40H; IMM40HPhase 1 ClinicalHematologic Neoplasms; Neoplasms; Solid tumours
상세
ALLO-316ALLO-316Phase 1 ClinicalCellectis Sa, Overland Pharmaceuticals (Shanghai) Co LtdCarcinoma, Renal Cell; Leukemia, Myeloid, Acute
상세
CD70 CAR T-cell therapy (Yake Biotechnology)Phase 1 ClinicalZhejiang UniversityLeukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma
상세
C-4-29Phase 1 ClinicalChongqing Precision Biotechnology Co LtdCarcinoma, Renal Cell; Lupus Erythematosus, Systemic; Multiple Myeloma
상세
[68Ga]Ga-NOTA-RCCB6ClinicalHuashan HospitalKidney Neoplasms; Lymphoma
상세
[18F]RCCB6ClinicalHuashan HospitalKidney Neoplasms
상세
CGC-738CGC-738; CGC738ClinicalSuzhou Cure Genetics Biosciences Co LtdCarcinoma, Renal Cell
상세
CD19/CD70 CAR-NK cells therapy (Rongu Biotechnology)RG-1970ClinicalHangzhou Rongu Biotechnology Co LtdLymphoma, B-Cell; Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호